Check Capital Management Inc. CA Grows Stock Position in Cardlytics, Inc. (NASDAQ:CDLX)

Check Capital Management Inc. CA raised its holdings in Cardlytics, Inc. (NASDAQ:CDLX) by 11.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,200 shares of the company’s stock after buying an additional 5,550 shares during the quarter. Check Capital Management Inc. CA’s holdings in Cardlytics were worth $209,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Atom Investors LP purchased a new position in shares of Cardlytics in the 3rd quarter worth $33,000. Tallon Kerry Patrick purchased a new position in shares of Cardlytics in the 4th quarter worth about $37,000. SG Americas Securities LLC acquired a new position in shares of Cardlytics in the 3rd quarter valued at about $45,000. Intech Investment Management LLC purchased a new stake in shares of Cardlytics during the 3rd quarter worth about $47,000. Finally, BNP Paribas Financial Markets increased its position in Cardlytics by 32.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock worth $63,000 after purchasing an additional 4,796 shares in the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CDLX shares. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Cardlytics has an average rating of “Hold” and an average target price of $6.92.

Insider Buying and Selling

In related news, CFO Alexis Desieno sold 8,854 shares of Cardlytics stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $32,494.18. Following the completion of the sale, the chief financial officer now owns 121,976 shares in the company, valued at approximately $447,651.92. The trade was a 6.77 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Amit Gupta sold 15,160 shares of the stock in a transaction on Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares in the company, valued at $844,736.48. This trade represents a 6.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,819 shares of company stock worth $148,305. 4.40% of the stock is currently owned by corporate insiders.

Cardlytics Stock Performance

Shares of CDLX stock opened at $3.56 on Friday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The company’s fifty day moving average price is $3.49 and its two-hundred day moving average price is $3.82. The firm has a market capitalization of $180.92 million, a P/E ratio of -0.58 and a beta of 1.54. Cardlytics, Inc. has a 12 month low of $2.76 and a 12 month high of $20.52.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.